Feramda
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of AS101 1% Oral Solution in Patients With Neovascular Age-Related Macular Degeneration (AMD) (NCT03216538) | Feramda | 2018-10-08 |
Track Feramda automatically
Every clearance here is in the API, with alerts when new ones post.